CURE Pharma open to US CRO contract in February 2019 by IR Team | Dec 11, 2018 | BlogCURE Pharma open to US CRO contract in February 2019 for PK/bioavailability study for thin film sildenafil, updates NASDAQ up-listing and partnering plans, CEO says CURE Pharmaceuticals (OTC:CURR) welcomes CRO approaches in February 2019 for a...
